Ssibon Pharmaceutical Private Limited
About Ssibon Pharmaceutical Private Limited
Data last updated:
Ssibon Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC343679. Its GSTIN is 07ABBCS3513P1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tuleshwar Singh and Neeta Singh Rajpoot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.71 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹13,530 (net margin 0.4%) and EBITDA of ₹13,530 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 33% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ssibon Pharmaceutical Private Limited
The main business activity of Ssibon Pharmaceutical is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ssibon Pharmaceutical Private Limited FY 2025 filings available
Ssibon Pharmaceutical Private Limited reported revenue of ₹30.71 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ssibon Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 19% growth in the latest year. EBITDA rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ssibon Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13,530 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13,530 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ssibon Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ssibon Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tuleshwar Singh | Director | 01 Jan 2019 | 7 Years 9 Months | Current |
| Neeta Singh Rajpoot | Director | 01 Jan 2019 | 7 Years 9 Months | Current |
Peer Comparison of Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Festive Realcon Private Limited | ₹30.72 Lakh (FY 2024) | •••• | •••• | 740.0% | •••• | Kolkata, West Bengal, India |
| House of Aynaa Private Limited | ₹30.72 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Indore, Madhya Pradesh, India |
| Evershine Fabrics Private Limited | ₹30.72 Lakh (FY 2019) | •••• | •••• | -65.0% | •••• | Kothapet X Road, Telangana, India |
| Crop Matrix Private Limited | ₹30.72 Lakh (FY 2024) | •••• | •••• | 420746.0% | •••• | Lucknow, Uttar Pradesh, India |
| Precision Ceramics Pvt Ltd | ₹30.72 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Kolkata, West Bengal, India |
| Ssibon Pharmaceutical Private Limited this company | ₹30.71 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Murli Foods (India) Pvt Ltd. | ₹30.71 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | Kolkata, West Bengal, India |
| Shiv-Shambho Consultants Private Limited | ₹30.7 Lakh (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Margaux Style and Accessories Private Limited | ₹30.7 Lakh (FY 2025) | •••• | •••• | 139.0% | •••• | Delhi, India |
| Shree Khyatija Tradelink Private Limited | ₹30.69 Lakh (FY 2023) | •••• | •••• | 28.0% | •••• | Pune, Maharashtra, India |
| Pioneer Lifesciences Enterprises Private Limited | ₹30.69 Lakh (FY 2025) | •••• | •••• | -89.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Ssibon Pharmaceutical by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Ssibon Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ssibon Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ssibon Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Neeta Singh Rajpoot was appointed as Director on 01 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for Ssibon Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ssibon Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ssibon Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABBCS3513P1Z4 | Delhi | Active | 11 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ssibon Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 January 2019 (7+ years old) and is registered under CIN U51909DL2019PTC343679.
Ssibon Pharmaceutical reported revenue of ₹30.71 Lakh for FY 2025 (up 19% YoY).
Ssibon Pharmaceutical has 2 current directors:
- Tuleshwar Singh - Director
- Neeta Singh Rajpoot - Director
Ssibon Pharmaceutical reported a net profit of ₹13,530 (net margin 0.4%) and EBITDA of ₹13,530 (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ssibon Pharmaceutical is 13% over three years and 33% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ssibon Pharmaceutical is 07ABBCS3513P1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Ssibon Pharmaceutical is U51909DL2019PTC343679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ssibon Pharmaceutical was incorporated on 01 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ssibon Pharmaceutical by revenue are Festive Realcon Private Limited, House of Aynaa Private Limited, Evershine Fabrics Private Limited, Crop Matrix Private Limited, Precision Ceramics Pvt Ltd and 5 more, all in the same principal business activity (Retail Trading).
Neeta Singh Rajpoot was appointed as Director on 01 Jan 2019. Tuleshwar Singh was appointed as Director on 01 Jan 2019.
The registered office of Ssibon Pharmaceutical is at 269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.